Joseph A Reddy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Joseph A Reddy

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Scientific Reports|July 31, 2020

Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agentJoseph A Reddy, Melissa Nelson, Christina Dircksen, et al.

Cancer Research|December 4, 2012

Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.

Molecular Cancer Therapeutics|June 4, 2016

High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Scientific Reports|July 31, 2020

Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agentJoseph A Reddy, Melissa Nelson, Christina Dircksen, et al.

Cancer Research|December 4, 2012

Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.

Molecular Cancer Therapeutics|June 4, 2016

High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.

Pageof 4